Filter Results
:
(597)
Show Results For
-
All HBS Web
(1,032)
- People (4)
- News (254)
- Research (597)
- Events (7)
- Multimedia (25)
- Faculty Publications (384)
Show Results For
-
All HBS Web
(1,032)
- People (4)
- News (254)
- Research (597)
- Events (7)
- Multimedia (25)
- Faculty Publications (384)
Sort by
- 09 Mar 2020
- Research & Ideas
Warring Algorithms Could Be Driving Up Consumer Prices
being in second place, it’s a pretty good place to be.” Consumers end up paying more To study how pricing algorithms affect competition, MacKay and Brown collected detailed pricing data from five large, multicategory retailers selling the same over-the-counter allergy...
View Details
- 23 Mar 2020
- Research & Ideas
Product Disasters Can Be Fertile Ground for Innovation
including a 20-article investigative series in the New York Times that discovered similar cases at other hospitals. The US Food and Drug Administration (FDA) started investigations of the CT devices, dozens of patients joined in a...
View Details
- 15 Apr 2008
- First Look
First Look: April 15, 2008
destructive behaviors such as cutting, excessive use of alcohol, taking drugs and suicide attempts. These patients are very difficult to treat and TBC has developed programs that make a noticeable difference to these patients. DBT...
View Details
Keywords:
Martha Lagace
- 05 Sep 2007
- First Look
First Look: September 5, 2007
value, or derail deals altogether. Consider, for example, the pharmaceutical company that deadlocked with a supplier over the issue of exclusivity in an ingredient purchase. Believing it was a ploy to raise the price, the drug maker upped...
View Details
Keywords:
Martha Lagace
- 19 Oct 2015
- Research & Ideas
Business Research that Makes for Smarter Public Policy
Ginger Jin, of the Maryland Center for Economics and Policy, is just one example. They invited regulatory officials from several leading federal agencies, including the Department of Agriculture (USDA), Environmental Protection Agency (EPA), Food and View Details
Keywords:
by Michael Blanding
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in...
View Details
Keywords:
Martha Lagace
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
at the US Food and Drug Administration and the Centers for Medicare and Medicaid Services. The pandemic has made it clear that this must change. Richard Hamermesh (@RHamermesh) is a Baker Foundation Professor of Management Practice and...
View Details
Keywords:
by Danielle Kost
- 24 Jun 2014
- First Look
First Look: June 24
malaria-"at no profit"-for public health systems. What had begun as an exemplary act of corporate responsibility had succeeded beyond any expectations. In 2012, for the second year in a row, Novartis had manufactured and distributed over 100 million units of...
View Details
Keywords:
Sean Silverthorne
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
profitability. In Chapter 6 we describe the work of drug company Cipla in India and telephone company China Mobile working in rural western China to bring affordable drugs, and smart telephone connections, respectively, to hundreds of...
View Details
Keywords:
by Martha Lagace
- 29 May 2001
- Research & Ideas
How Technological Disruption Changes Everything
and, finally, self-care. Microsoft has way overshot what the customer needs. —Clayton Christensen Christensen said that disruptive technologies in health care are coming in the form of better and more targeted drugs and rapidly improving...
View Details
- 10 Sep 2007
- Research & Ideas
High Note: Managing the Medici String Quartet
Robertson working for you as your key software developer, drug researcher, or designer, he would be a handful, to say the least. There are key people in these kinds of businesses, and they are what they are. One of the managing partners...
View Details
- 18 Apr 2019
- Research & Ideas
Open Innovation Contestants Build AI-Based Cancer Tool
for Google, etc. AI is already being used as an adjunct to diagnosis in some settings. However, the bar for US Food & Drug Administration approval for a diagnostic test is appropriately high, and “products” will need to meet this bar...
View Details
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
Ph.D. in biology and a former biology professor at Harvard, has also had a 25-year career in drug development and biotech companies, leading both R&D and business functions. She teaches the MBA elective Inventing Breakthroughs and...
View Details
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research servers that hold data on promising View Details
- 14 Dec 2010
- First Look
First Look: Dec. 14
511-075 By 2009, Hikma Pharmaceuticals operated 13 manufacturing plants in 8 countries of which 5 were approved by the U.S. Food and Drug Administration. Hikma tracked its sales revenues over the period to show from where the largest...
View Details
Keywords:
Sean Silverthorne
- 06 Jun 2017
- First Look
First Look at New Research and Ideas: June 6, 2017
with revenue expectations of $1 billion in 2015. At the time of the acquisition, AbbVie received more than 60% of its sales from the drug Humira, a biologic agent used to treat several autoimmune diseases and malignancies. However, Humira...
View Details
Keywords:
Sean Silverthorne
- 19 Jun 2012
- First Look
First Look: June 19
312-002 McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company, with $122 billion in 2010...
View Details
Keywords:
Sean Silverthorne
- 27 Feb 2018
- First Look
First Look at New Research and Ideas, February 27, 2018
company. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/718403-PDF-ENG Harvard Business School Case 618-033 BeiGene BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges...
View Details
Keywords:
Sean Silverthorne
- 28 May 2014
- Research & Ideas
Building Histories of Emerging Economies One Interview at a Time
you are saving lives. So it has to have a humanitarian angle to it." (Cipla manufactures generic versions of a number of commonly prescribed medicines and is the world's largest manufacturer of the antiretroviral drugs that fight HIV and...
View Details
Keywords:
by Julia Hanna
- 08 Aug 2011
- Research & Ideas
The Death of the Global Manager
and its efforts to establish Humanitarian Assistance for Neglected Diseases (HAND), a corporate social responsibility program focused on treatments for diseases that typically affect too small a population to warrant the attention of drug...
View Details
Keywords:
by Julia Hanna